<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27449815</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>11</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1943-0264</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>8</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2016</Year>
              <Month>Sep</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cold Spring Harbor perspectives in biology</Title>
          <ISOAbbreviation>Cold Spring Harb Perspect Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>TGF-β Signaling from Receptors to Smads.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">a022061</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1101/cshperspect.a022061</ELocationID>
        <Abstract>
          <AbstractText>Transforming growth factor β (TGF-β) and related growth factors are secreted pleiotropic factors that play critical roles in embryogenesis and adult tissue homeostasis by regulating cell proliferation, differentiation, death, and migration. The TGF-β family members signal via heteromeric complexes of type I and type II receptors, which activate members of the Smad family of signal transducers. The main attribute of the TGF-β signaling pathway is context-dependence. Depending on the concentration and type of ligand, target tissue, and developmental stage, TGF-β family members transmit distinct signals. Deregulation of TGF-β signaling contributes to developmental defects and human diseases. More than a decade of studies have revealed the framework by which TGF-βs encode a context-dependent signal, which includes various positive and negative modifiers of the principal elements of the signaling pathway, the receptors, and the Smad proteins. In this review, we first introduce some basic components of the TGF-β signaling pathways and their actions, and then discuss posttranslational modifications and modulatory partners that modify the outcome of the signaling and contribute to its context-dependence, including small noncoding RNAs.</AbstractText>
          <CopyrightInformation>Copyright © 2016 Cold Spring Harbor Laboratory Press; all rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hata</LastName>
            <ForeName>Akiko</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94143.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Ye-Guang</ForeName>
            <Initials>YG</Initials>
            <AffiliationInfo>
              <Affiliation>The State Key Laboratory of Membrane Biology, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 HL116191</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 HL132058</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>09</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cold Spring Harb Perspect Biol</MedlineTA>
        <NlmUniqueID>101513680</NlmUniqueID>
        <ISSNLinking>1943-0264</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051785">Smad Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051785" MajorTopicYN="N">Smad Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>7</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>7</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27449815</ArticleId>
        <ArticleId IdType="mid">NIHMS938351</ArticleId>
        <ArticleId IdType="pmc">PMC5008074</ArticleId>
        <ArticleId IdType="doi">10.1101/cshperspect.a022061</ArticleId>
        <ArticleId IdType="pii">cshperspect.a022061</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Abdollah S, Macias-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL. 1997. 
TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2–Smad4 complex formation and signaling. J Biol Chem
272: 27678–27685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9346908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agricola E, Randall RA, Gaarenstroom T, Dupont S, Hill CS. 2011. 
Recruitment of TIF1γ to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities. Mol Cell
43: 85–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21726812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmed MI, Mardaryev AN, Lewis CJ, Sharov AA, Botchkareva NV. 2011. 
MicroRNA-21 is an important downstream component of BMP signalling in epidermal keratinocytes. J Cell Sci
124: 3399–3404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3196856</ArticleId>
            <ArticleId IdType="pubmed">21984808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ, et al.
2009. 
Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell
139: 757–769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2818353</ArticleId>
            <ArticleId IdType="pubmed">19914168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Salihi MA, Herhaus L, Macartney T, Sapkota GP. 2012. 
USP11 augments TGFβ signalling by deubiquitylating ALK5. Open Biol
2: 120063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3390794</ArticleId>
            <ArticleId IdType="pubmed">22773947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aragon E, Goerner N, Zaromytidou AI, Xi Q, Escobedo A, Massagué J, Macias MJ. 2011. 
A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev
25: 1275–1288.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3127429</ArticleId>
            <ArticleId IdType="pubmed">21685363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atfi A, Dumont E, Colland F, Bonnier D, L’Helgoualc’h A, Prunier C, Ferrand N, Clement B, Wewer UM, Theret N. 2007. 
The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signaling through interaction with the type II receptor. J Cell Biol
178: 201–208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2064440</ArticleId>
            <ArticleId IdType="pubmed">17620406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bai Y, Yang W, Yang HX, Liao Q, Ye G, Fu G, Ji L, Xu P, Wang H, Li YX, et al.
2012. 
Downregulated miR-195 detected in preeclamptic placenta affects trophoblast cell invasion via modulating ActRIIA expression. PLoS ONE
7: e38875.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3378540</ArticleId>
            <ArticleId IdType="pubmed">22723898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bakkebo M, Huse K, Hilden VI, Forfang L, Myklebust JH, Smeland EB, Oksvold MP. 2012. 
SARA is dispensable for functional TGF-β signaling. FEBS Lett
586: 3367–3372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22819827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balderman JA, Lee HY, Mahoney CE, Handy DE, White K, Annis S, Lebeche D, Hajjar RJ, Loscalzo J, Leopold JA. 2012. 
Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification. J Am Heart Assoc
1: e003905.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3540659</ArticleId>
            <ArticleId IdType="pubmed">23316327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bao Y, Chen Z, Guo Y, Feng Y, Li Z, Han W, Wang J, Zhao W, Jiao Y, Li K, et al.
2014. 
Tumor suppressor microRNA-27a in colorectal carcinogenesis and progression by targeting SGPP1 and Smad2. PLoS ONE
9: e105991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4148394</ArticleId>
            <ArticleId IdType="pubmed">25166914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bardeesy N, Cheng KH, Berger JH, Chu GC, Pahler J, Olson P, Hezel AF, Horner J, Lauwers GY, Hanahan D, et al.
2006. 
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev
20: 3130–3146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1635148</ArticleId>
            <ArticleId IdType="pubmed">17114584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batut J, Howell M, Hill CS. 2007. 
Kinesin-mediated transport of Smad2 is required for signaling in response to TGF-β ligands. Dev Cell
12: 261–274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17276343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bengtsson L, Schwappacher R, Roth M, Boergermann JH, Hassel S, Knaus P. 2009. 
PP2A regulates BMP signalling by interacting with BMP receptor complexes and by dephosphorylating both the C-terminus and the linker region of Smad1. J Cell Sci
122: 1248–1257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19339557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett D, Alphey L. 2002. 
PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster. Nat Genet
31: 419–423.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12134149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berenguer J, Herrera A, Vuolo L, Torroba B, Llorens F, Sumoy L, Pons S. 2013. 
MicroRNA 22 regulates cell cycle length in cerebellar granular neuron precursors. Mol Cell Biol
33: 2706–2717.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3700129</ArticleId>
            <ArticleId IdType="pubmed">23671190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blahna MT, Hata A. 2012. 
Smad-mediated regulation of microRNA biosynthesis. FEBS Lett
586: 1906–1912.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4429768</ArticleId>
            <ArticleId IdType="pubmed">22306316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blahna MT, Hata A. 2013. 
Regulation of miRNA biogenesis as an integrated component of growth factor signaling. Curr Opin Cell Biol
25: 233–240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4429755</ArticleId>
            <ArticleId IdType="pubmed">23312066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blumensatt M, Greulich S, Herzfeld de Wiza D, Mueller H, Maxhera B, Rabelink MJ, Hoeben RC, Akhyari P, Al-Hasani H, Ruige JB, et al.
2013. 
Activin A impairs insulin action in cardiomyocytes via up-regulation of miR-143. Cardiovasc Res
100: 201–210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23812417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bruce DL, Macartney T, Yong W, Shou W, Sapkota GP. 2012. 
Protein phosphatase 5 modulates SMAD3 function in the transforming growth factor-β pathway. Cell Signal
24: 1999–2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22781750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T. 2008. 
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep
9: 582–589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2396950</ArticleId>
            <ArticleId IdType="pubmed">18483486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao H, Jheon A, Li X, Sun Z, Wang J, Florez S, Zhang Z, McManus MT, Klein OD, Amendt BA. 2013. 
The Pitx2: miR-200c/141:noggin pathway regulates Bmp signaling and ameloblast differentiation. Development
140: 3348–3359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3737717</ArticleId>
            <ArticleId IdType="pubmed">23863486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cárcamo J, Zentella A, Massagué J. 1995. 
Disruption of transforming growth factor β signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol Cell Biol
15: 1573–1581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC230381</ArticleId>
            <ArticleId IdType="pubmed">7862150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen RH, Derynck R. 1994. 
Homomeric interactions between type II transforming growth factor-β receptors. J Biol Chem
269: 22868–22874.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7521335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen RH, Miettinen PJ, Maruoka EM, Choy L, Derynck R. 1995. 
A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature
377: 548–552.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7566156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen YG, Liu F, Massagué J. 1997. 
Mechanism of TGF-β receptor inhibition by FKBP12. EMBO J
16: 3866–3876.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1170011</ArticleId>
            <ArticleId IdType="pubmed">9233797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen YG, Hata A, Lo RS, Wotton D, Shi Y, Pavletich N, Massagué J. 1998. 
Determinants of specificity in TGF-β signal transduction. Genes Dev
12: 2144–2152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC317013</ArticleId>
            <ArticleId IdType="pubmed">9679059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen HB, Rud JG, Lin K, Xu L. 2005. 
Nuclear targeting of transforming growth factor-β-activated Smad complexes. J Biol Chem
280: 21329–21336.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15799969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen HB, Shen J, Ip YT, Xu L. 2006. 
Identification of phosphatases for Smad in the BMP/DPP pathway. Genes Dev
20: 648–653.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1413280</ArticleId>
            <ArticleId IdType="pubmed">16510868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen YG, Wang Z, Ma J, Zhang L, Lu Z. 2007. 
Endofin, a FYVE domain protein, interacts with Smad4 and facilitates transforming growth factor-β signaling. J Biol Chem
282: 9688–9695.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17272273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen F, Lin X, Xu P, Zhang Z, Chen Y, Wang C, Han J, Zhao B, Xiao M, Feng XH. 2015. 
Nuclear export of Smads by RanBP3L regulates bone morphogenetic protein signaling and mesenchymal stem cell differentiation. Mol Cell Biol
35: 1700–1711.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4405638</ArticleId>
            <ArticleId IdType="pubmed">25755279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheung KS, Sposito N, Stumpf PS, Wilson DI, Sanchez-Elsner T, Oreffo RO. 2014. 
MicroRNA-146a regulates human foetal femur derived skeletal stem cell differentiation by down-regulating SMAD2 and SMAD3. PLoS ONE
9: e98063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4043645</ArticleId>
            <ArticleId IdType="pubmed">24892945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi SJ, Moon JH, Ahn YW, Ahn JH, Kim DU, Han TH. 2005. 
Tsc-22 enhances TGF-β signaling by associating with Smad4 and induces erythroid cell differentiation. Mol Cell Biochem
271: 23–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15881652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choy L, Derynck R. 1998. 
The type II transforming growth factor (TGF)-β receptor-interacting protein TRIP-1 acts as a modulator of the TGF-β response. J Biol Chem
273: 31455–31462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9813058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colas AR, McKeithan WL, Cunningham TJ, Bushway PJ, Garmire LX, Duester G, Subramaniam S, Mercola M. 2012. 
Whole-genome microRNA screening identifies let-7 and mir-18 as regulators of germ layer formation during early embryogenesis. Genes Dev
26: 2567–2579.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3521625</ArticleId>
            <ArticleId IdType="pubmed">23152446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conery AR, Cao Y, Thompson EA, Townsend CM Jr, Ko TC, Luo K. 2004. 
Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β induced apoptosis. Nat Cell Biol
6: 366–372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15104092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, Benos PV. 2009. 
Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS ONE
4: e5279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2668758</ArticleId>
            <ArticleId IdType="pubmed">19390574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai F, Lin X, Chang C, Feng XH. 2009. 
Nuclear export of Smad2 and Smad3 by RanBP3 facilitates termination of TGF-β signaling. Dev Cell
16: 345–357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2676691</ArticleId>
            <ArticleId IdType="pubmed">19289081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Datta PK, Moses HL. 2000. 
STRAP and Smad7 synergize in the inhibition of transforming growth factorβ signaling. Mol Cell Biol
20: 3157–3167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC85610</ArticleId>
            <ArticleId IdType="pubmed">10757800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Datta PK, Chytil A, Gorska AE, Moses HL. 1998. 
Identification of STRAP, a novel WD domain protein in transforming growth factor-β signaling. J Biol Chem
273: 34671–34674.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9856985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis BN, Hilyard AC, Lagna G, Hata A. 2008. 
SMAD proteins control DROSHA-mediated microRNA maturation. Nature
454: 56–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2653422</ArticleId>
            <ArticleId IdType="pubmed">18548003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. 2010. 
Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell
39: 373–384.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2921543</ArticleId>
            <ArticleId IdType="pubmed">20705240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis-Dusenbery BN, Chan MC, Reno KE, Weisman AS, Layne MD, Lagna G, Hata A. 2011. 
Down-regulation of Krüppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-β and bone morphogenetic protein 4. J Biol Chem
286: 28097–28110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3151055</ArticleId>
            <ArticleId IdType="pubmed">21673106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deheuninck J, Luo K. 2009. 
Ski and SnoN, potent negative regulators of TGF-β signaling. Cell Res
19: 47–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3103856</ArticleId>
            <ArticleId IdType="pubmed">19114989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Strooper B, Iwatsubo T, Wolfe MS. 2012. 
Presenilins and γ-secretase: Structure, function, and role in Alzheimer disease. Cold Spring Harb Perspect Med
2: a006304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3253024</ArticleId>
            <ArticleId IdType="pubmed">22315713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du J, Yang S, An D, Hu F, Yuan W, Zhai C, Zhu T. 2009. 
BMP-6 inhibits microRNA-21 expression in breast cancer through repressing δEF1 and AP-1. Cell Res
19: 487–496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19308091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duan X, Liang YY, Feng XH, Lin X. 2006. 
Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem
281: 36526–36532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16931515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunworth WP, Cardona-Costa J, Bozkulak EC, Kim JD, Meadows S, Fischer JC, Wang Y, Cleaver O, Qyang Y, Ober EA, et al.
2014. 
Bone morphogenetic protein 2 signaling negatively modulates lymphatic development in vertebrate embryos. Circ Res
114: 56–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4047637</ArticleId>
            <ArticleId IdType="pubmed">24122719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dupont S, Zacchigna L, Cordenonsi M, Soligo S, Adorno M, Rugge M, Piccolo S. 2005. 
Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell
121: 87–99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15820681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, Adorno M, Martello G, Stinchfield MJ, Soligo S, Morsut L, et al.
2009. 
FAM/USP9x, a deubiquitinating enzyme essential for TGF-β signaling, controls Smad4 monoubiquitination. Cell
136: 123–135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19135894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Durrington HJ, Upton PD, Hoer S, Boname J, Dunmore BJ, Yang J, Crilley TK, Butler LM, Blackbourn DJ, Nash GB, et al.
2010. 
Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II. J Biol Chem
285: 37641–37649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2988369</ArticleId>
            <ArticleId IdType="pubmed">20870717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K. 2001. 
Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J Biol Chem
276: 12477–12480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11278251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng XH, Derynck R. 1997. 
A kinase subdomain of transforming growth factor-β (TGF-β) type I receptor determines the TGF-β intracellular signaling specificity. EMBO J
16: 3912–3923.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1170015</ArticleId>
            <ArticleId IdType="pubmed">9233801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng XH, Derynck R. 2005. 
Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol
21: 659–693.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16212511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrand N, Atfi A, Prunier C. 2010. 
The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-β type I receptor. Cancer Res
70: 8457–8466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20959473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flotho A, Melchior F. 2013. 
Sumoylation: A regulatory protein modification in health and disease. Annu Rev Biochem
82: 357–385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23746258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu G, Ye G, Nadeem L, Ji L, Manchanda T, Wang Y, Zhao Y, Qiao J, Wang YL, Lye S, et al.
2013. 
MicroRNA-376c impairs transforming growth factor-β and nodal signaling to promote trophoblast cell proliferation and invasion. Hypertension
61: 864–872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23424236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM, De Robertis EM. 2007. 
Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell
131: 980–993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2200633</ArticleId>
            <ArticleId IdType="pubmed">18045539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukasawa H, Yamamoto T, Fujigaki Y, Misaki T, Ohashi N, Takayama T, Suzuki S, Mugiya S, Oda T, Uchida C, et al.
2010. 
Reduction of transforming growth factor-β type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma. Int J Cancer
127: 1517–1525.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20073064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukuchi M, Imamura T, Chiba T, Ebisawa T, Kawabata M, Tanaka K, Miyazono K. 2001. 
Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell
12: 1431–1443.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC34595</ArticleId>
            <ArticleId IdType="pubmed">11359933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukuda T, Yamagata K, Fujiyama S, Matsumoto T, Koshida I, Yoshimura K, Mihara M, Naitou M, Endoh H, Nakamura T, et al.
2007. 
DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Bio
9: 604–611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17435748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furuhashi M, Yagi K, Yamamoto H, Furukawa Y, Shimada S, Nakamura Y, Kikuchi A, Miyazono K, Kato M. 2001. 
Axin facilitates Smad3 activation in the transforming growth factor β signaling pathway. Mol Cell Biol
21: 5132–5141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC87238</ArticleId>
            <ArticleId IdType="pubmed">11438668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao S, Alarcon C, Sapkota G, Rahman S, Chen PY, Goerner N, Macias MJ, Erdjument-Bromage H, Tempst P, Massagué J. 2009. 
Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-β signaling. Mol Cell
36: 457–468.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2796330</ArticleId>
            <ArticleId IdType="pubmed">19917253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaughwin P, Ciesla M, Yang H, Lim B, Brundin P. 2011. 
Stage-specific modulation of cortical neuronal development by Mμ-miR-134. Cereb Cortex
21: 1857–1869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21228099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gilboa L, Wells RG, Lodish HF, Henis YI. 1998. 
Oligomeric structure of type I and type II transforming growth factor β receptors: Homodimers form in the ER and persist at the plasma membrane. J Cell Biol
140: 767–777.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2141740</ArticleId>
            <ArticleId IdType="pubmed">9472030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goh JB, Wallace DF, Hong W, Subramaniam VN. 2015. 
Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidin. Sci Rep
5: 13986.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4566084</ArticleId>
            <ArticleId IdType="pubmed">26358513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. 2008. 
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol
10: 593–601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18376396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Griswold-Prenner I, Kamibayashi C, Maruoka EM, Mumby MC, Derynck R. 1998. 
Physical and functional interactions between type I transforming growth factor β receptors and Ba, a WD-40 repeat subunit of phosphatase 2A. Mol Cell Biol
18: 6595–6604.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC109244</ArticleId>
            <ArticleId IdType="pubmed">9774674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grönroos E, Hellman U, Heldin CH, Ericsson J. 2002. 
Control of Smad7 stability by competition between acetylation and ubiquitination. Mol Cell
10: 483–493.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12408818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Groppe J, Hinck CS, Samavarchi-Tehrani P, Zubieta C, Schuermann JP, Taylor AB, Schwarz PM, Wrana JL, Hinck AP. 2008. 
Cooperative assembly of TGF-β superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol Cell
29: 157–168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18243111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gudey SK, Sundar R, Mu Y, Wallenius A, Zang G, Bergh A, Heldin CH, Landstrom M. 2014. 
TRAF6 stimulates the tumor-promoting effects of TGF-β type I receptor through polyubiquitination and activation of presenilin 1. Sci Signal
7: ra2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24399296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang XF. 2008. 
Axin and GSK3-β control Smad3 protein stability and modulate TGF-β signaling. Genes Dev
22: 106–120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2151009</ArticleId>
            <ArticleId IdType="pubmed">18172167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo M, Jiang Z, Zhang X, Lu D, Ha AD, Sun J, Du W, Wu Z, Hu L, Khadarian K, et al.
2014. 
miR-656 inhibits glioma tumorigenesis through repression of BMPR1A. Carcinogenesis
35: 1698–1706.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24480809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ha M, Kim VN. 2014. 
Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol
15: 509–524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25027649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hartung A, Bitton-Worms K, Rechtman MM, Wenzel V, Boergermann JH, Hassel S, Henis YI, Knaus P. 2006. 
Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol
26: 7791–7805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1636853</ArticleId>
            <ArticleId IdType="pubmed">16923969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hata A, Lieberman J. 2015. 
Dysregulation of microRNA biogenesis and gene silencing in cancer. Sci Signal
8: re3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25783160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr, Wrana JL, et al.
1997. 
The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell
89: 1165–1173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9215638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massagué J. 2006. 
Hematopoiesis controlled by distinct TIF1γ and Smad4 branches of the TGF-β pathway. Cell
125: 929–941.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16751102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henis YI, Moustakas A, Lin HY, Lodish HF. 1994. 
The types II and III transforming growth factor-β receptors form homo-oligomers. J Cell Biol
126: 139–154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2120107</ArticleId>
            <ArticleId IdType="pubmed">8027173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hill CS. 2009. 
Nucleocytoplasmic shuttling of Smad proteins. Cell Res
19: 36–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19114992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hocevar BA, Smine A, Xu XX, Howe PH. 2001. 
The adaptor molecule disabled-2 links the transforming growth factor β receptors to the Smad pathway. EMBO J
20: 2789–2801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC125498</ArticleId>
            <ArticleId IdType="pubmed">11387212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu F, Meng X, Tong Q, Liang L, Xiang R, Zhu T, Yang S. 2013. 
BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer. Biochim Biophys Acta
1832: 2379–2390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24012720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang F, Chen YG. 2012. 
Regulation of TGF-β receptor activity. Cell Biosci
2: 9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3333473</ArticleId>
            <ArticleId IdType="pubmed">22420375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang S, He X, Ding J, Liang L, Zhao Y, Zhang Z, Yao X, Pan Z, Zhang P, Li J, et al.
2008. 
Upregulation of miR-23a∼ 27a∼24 decreases transforming growth factor-β-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer
123: 972–978.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18508316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang T, David L, Mendoza V, Yang Y, Villarreal M, De K, Sun L, Fang X, Lopez-Casillas F, Wrana JL, et al.
2011. 
TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs. EMBO J
30: 1263–1276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3094126</ArticleId>
            <ArticleId IdType="pubmed">21423151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huse M, Chen YG, Massagué J, Kuriyan J. 1999. 
Crystal structure of the cytoplasmic domain of the type I TGFβ receptor in complex with FKBP12. Cell
96: 425–436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10025408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massagué J. 2001. 
The TGFβ receptor activation process: An inhibitor- to substrate-binding switch. Mol Cell
8: 671–682.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11583628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwang S, Park SK, Lee HY, Kim SW, Lee JS, Choi EK, You D, Kim CS, Suh N. 2014. 
miR-140–5p suppresses BMP2-mediated osteogenesis in undifferentiated human mesenchymal stem cells. FEBS Lett
588: 2957–2963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24928442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imamura T, Oshima Y, Hikita A. 2013. 
Regulation of TGF-β family signalling by ubiquitination and deubiquitination. J Biochem
154: 481–489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24165200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoue Y, Itoh Y, Abe K, Okamoto T, Daitoku H, Fukamizu A, Onozaki K, Hayashi H. 2007. 
Smad3 is acetylated by p300/CBP to regulate its transactivation activity. Oncogene
26: 500–508.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16862174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inui M, Manfrin A, Mamidi A, Martello G, Morsut L, Soligo S, Enzo E, Moro S, Polo S, Dupont S, et al.
2011. 
USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat Cell Biol
13: 1368–1375.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21947082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Itoh F, Divecha N, Brocks L, Oomen L, Janssen H, Calafat J, Itoh S, Dijke Pt P. 2002. 
The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-β/Smad signalling. Genes Cells
7: 321–331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11918675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Itoh S, Thorikay M, Kowanetz M, Moustakas A, Itoh F, Heldin CH, ten Dijke P. 2003. 
Elucidation of Smad requirement in transforming growth factor-β type I receptor-induced responses. J Biol Chem
278: 3751–3761.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12446693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Itoh T, Nozawa Y, Akao Y. 2009. 
MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem
284: 19272–19279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2740552</ArticleId>
            <ArticleId IdType="pubmed">19454767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin Q, Gao G, Mulder KM. 2009. 
Requirement of a dynein light chain in TGF-β/Smad3 signaling. J Cell Physiol
221: 707–715.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2881827</ArticleId>
            <ArticleId IdType="pubmed">19711352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang Y, Chen CR, Massagué J. 2003. 
A self-enabling TGF-β response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell
11: 915–926.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12718878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang JS, Saunier EF, Akhurst RJ, Derynck R. 2008. 
The type I TGF-β receptor is covalently modified and regulated by sumoylation. Nat Cell Biol
10: 654–664.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2649123</ArticleId>
            <ArticleId IdType="pubmed">18469808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang JS, Liu C, Derynck R. 2009. 
New regulatory mechanisms of TGF-β receptor function. Trends Cell Biol
19: 385–394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19648010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. 2000. 
Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol Cell
6: 1365–1375.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11163210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawamata H, Fujimori T, Imai Y. 2004. 
TSC-22 (TGF-β stimulated clone-22): A novel molecular target for differentiation-inducing therapy in salivary gland cancer. Curr Cancer Drug Targets
4: 521–529.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15379637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawasaki K, Freimuth J, Meyer DS, Lee MM, Tochimoto-Okamoto A, Benzinou M, Clermont FF, Wu G, Roy R, Letteboer TG, et al.
2014. 
Genetic variants of Adam17 differentially regulate TGF-β signaling to modify vascular pathology in mice and humans. Proc Natl Acad Sci
111: 7723–7728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4040598</ArticleId>
            <ArticleId IdType="pubmed">24812125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim YJ, Hwang SJ, Bae YC, Jung JS. 2009. 
MiR-21 regulates adipogenic differentiation through the modulation of TGF-β signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells
27: 3093–3102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19816956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim SJ, Oh JS, Shin JY, Lee KD, Sung KW, Nam SJ, Chun KH. 2011. 
Development of microRNA-145 for therapeutic application in breast cancer. J Control Release
155: 427–434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21723890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim S, Hata A, Kang H. 2014. 
Down-regulation of miR-96 by bone morphogenetic protein signaling is critical for vascular smooth muscle cell phenotype modulation. J Cell Biochem
115: 889–895.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5215840</ArticleId>
            <ArticleId IdType="pubmed">24375867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Komuro A, Imamura T, Saitoh M, Yoshida Y, Yamori T, Miyazono K, Miyazawa K. 2004. 
Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1). Oncogene
23: 6914–6923.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15221015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korpal M, Lee ES, Hu G, Kang Y. 2008. 
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem
283: 14910–14914.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3258899</ArticleId>
            <ArticleId IdType="pubmed">18411277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kowanetz M, Lönn P, Vanlandewijck M, Kowanetz K, Heldin CH, Moustakas A. 2008. 
TGF-β induces SIK to negatively regulate type I receptor kinase signaling. J Cell Biol
182: 655–662.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2518705</ArticleId>
            <ArticleId IdType="pubmed">18725536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kretzschmar M, Doody J, Massagué J. 1997. 
Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature
389: 618–622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9335504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuratomi G, Komuro A, Goto K, Shinozaki M, Miyazawa K, Miyazono K, Imamura T. 2005. 
NEDD 4–2 (neural precursor cell expressed, developmentally down-regulated 4–2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor. Biochem J
386: 461–470.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1134864</ArticleId>
            <ArticleId IdType="pubmed">15496141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurisaki A, Kose S, Yoneda Y, Heldin CH, Moustakas A. 2001. 
Transforming growth factor-β induces nuclear import of Smad3 in an importin-β1 and Ran-dependent manner. Mol Biol Cell
12: 1079–1091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC32288</ArticleId>
            <ArticleId IdType="pubmed">11294908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurisaki A, Kurisaki K, Kowanetz M, Sugino H, Yoneda Y, Heldin CH, Moustakas A. 2006. 
The mechanism of nuclear export of Smad3 involves exportin 4 and Ran. Mol Cell Biol
26: 1318–1332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1367208</ArticleId>
            <ArticleId IdType="pubmed">16449645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Labbé E, Letamendia A, Attisano L. 2000. 
Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways. Proc Natl Acad Sci
97: 8358–8363.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC26952</ArticleId>
            <ArticleId IdType="pubmed">10890911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Labbé E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, Moses HL, Attisano L. 2007. 
Transcriptional cooperation between the transforming growth factor-β and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res
67: 75–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17210685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawler S, Feng XH, Chen RH, Maruoka EM, Turck CW, Griswold-Prenner I, Derynck R. 1997. 
The type II transforming growth factor-β receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem
272: 14850–14859.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9169454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee PS, Chang C, Liu D, Derynck R. 2003. 
Sumoylation of Smad4, the common Smad mediator of transforming growth factor-β family signaling. J Biol Chem
278: 27853–27863.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12740389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM, Derynck R. 2007. 
TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J
26: 3957–3967.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1994119</ArticleId>
            <ArticleId IdType="pubmed">17673906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Scolan E, Zhu Q, Wang L, Bandyopadhyay A, Javelaud D, Mauviel A, Sun L, Luo K. 2008. 
Transforming growth factor-β suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res
68: 3277–3285.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18451154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy L, Howell M, Das D, Harkin S, Episkopou V, Hill CS. 2007. 
Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol
27: 6068–6083.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1952153</ArticleId>
            <ArticleId IdType="pubmed">17591695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li L, Xin H, Xu X, Huang M, Zhang X, Chen Y, Zhang S, Fu XY, Chang Z. 2004. 
CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. Mol Cell Biol
24: 856–864.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC343794</ArticleId>
            <ArticleId IdType="pubmed">14701756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, Lian JB, Stein GS. 2008. 
A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci
105: 13906–13911.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2544552</ArticleId>
            <ArticleId IdType="pubmed">18784367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li L, Shi JY, Zhu GQ, Shi B. 2012. 
MiR-17–92 cluster regulates cell proliferation and collagen synthesis by targeting TGFβ pathway in mouse palatal mesenchymal cells. J Cell Biochem
113: 1235–1244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22095742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang H, Xu C, Pan Z, Zhang Y, Xu Z, Chen Y, Li T, Li X, Liu Y, Huangfu L, et al.
2014. 
The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Mol Ther
22: 1122–1133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4048895</ArticleId>
            <ArticleId IdType="pubmed">24594795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. 2005. 
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature
433: 769–773.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15685193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin HY, Wang XF. 1992. 
Expression cloning of TGF-β receptors. Mol Reprod Dev
32: 105–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1322147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF. 1992. 
Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell
68: 775–785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1310899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin X, Liang M, Feng XH. 2000. 
Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-β signaling. J Biol Chem
275: 36818–36822.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11016919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin X, Liang M, Liang YY, Brunicardi FC, Melchior F, Feng XH. 2003. 
Activation of transforming growth factor-β signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4. J Biol Chem
278: 18714–18719.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12621041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin HK, Bergmann S, Pandolfi PP. 2004. 
Cytoplasmic PML function in TGF-β signalling. Nature
431: 205–211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15356634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J, Hu M, Davis CM, Wang J, Brunicardi FC, et al.
2006. 
PPM1A functions as a Smad phosphatase to terminate TGF-β signaling. Cell
125: 915–928.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6309366</ArticleId>
            <ArticleId IdType="pubmed">16751101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin EA, Kong L, Bai XH, Luan Y, Liu CJ. 2009. 
miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. J Biol Chem
284: 11326–11335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2670138</ArticleId>
            <ArticleId IdType="pubmed">19251704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin HS, Gong JN, Su R, Chen MT, Song L, Shen C, Wang F, Ma YN, Zhao HL, Yu J, et al.
2014. 
miR-199a-5p inhibits monocyte/macrophage differentiation by targeting the activin A type 1B receptor gene and finally reducing C/EBPα expression. J Leukoc Biol
96: 1023–1035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25258381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindsay ME, Holaska JM, Welch K, Paschal BM, Macara IG. 2001. 
Ran-binding protein 3 is a cofactor for Crm1-mediated nuclear protein export. J Cell Biol
153: 1391–1402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2150735</ArticleId>
            <ArticleId IdType="pubmed">11425870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipchina I, Elkabetz Y, Hafner M, Sheridan R, Mihailovic A, Tuschl T, Sander C, Studer L, Betel D. 2011. 
Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. Genes Dev
25: 2173–2186.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3205587</ArticleId>
            <ArticleId IdType="pubmed">22012620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. 1997. 
Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci
94: 10669–10674.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC23442</ArticleId>
            <ArticleId IdType="pubmed">9380693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu W, Rui H, Wang J, Lin S, He Y, Chen M, Li Q, Ye Z, Zhang S, Chan SC, et al.
2006. 
Axin is a scaffold protein in TGF-β signaling that promotes degradation of Smad7 by Arkadia. EMBO J
25: 1646–1658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1440825</ArticleId>
            <ArticleId IdType="pubmed">16601693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu C, Xu P, Lamouille S, Xu J, Derynck R. 2009. 
TACE-mediated ectodomain shedding of the type I TGF-β receptor downregulates TGF-β signaling. Mol Cell
35: 26–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2740991</ArticleId>
            <ArticleId IdType="pubmed">19595713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Ma Y, Zhang C, Wei S, Cao Y, Wang Q. 2013. 
Nodal promotes mir206 expression to control convergence and extension movements during zebrafish gastrulation. J Genet Genomics
40: 515–521.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24156917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lo RS, Chen YG, Shi Y, Pavletich NP, Massagué J. 1998. 
The L3 loop: A structural motif determining specific interactions between SMAD proteins and TGF-β receptors. EMBO J
17: 996–1005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1170449</ArticleId>
            <ArticleId IdType="pubmed">9463378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lo SS, Hung PS, Chen JH, Tu HF, Fang WL, Chen CY, Chen WT, Gong NR, Wu CW. 2012. 
Overexpression of miR-370 and downregulation of its novel target TGF-β-RII contribute to the progression of gastric carcinoma. Oncogene
31: 226–237.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21666718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long J, Wang G, He D, Liu F. 2004. 
Repression of Smad4 transcriptional activity by SUMO modification. Biochem J
379: 23–29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1224064</ArticleId>
            <ArticleId IdType="pubmed">14750902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long J, Badal SS, Wang Y, Chang BH, Rodriguez A, Danesh FR. 2013. 
MicroRNA-22 is a master regulator of bone morphogenetic protein-7/6 homeostasis in the kidney. J Biol Chem
288: 36202–36214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3868735</ArticleId>
            <ArticleId IdType="pubmed">24163368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lönn P, Morén A, Raja E, Dahl M, Moustakas A. 2009. 
Regulating the stability of TGF-β receptors and Smads. Cell Res
19: 21–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19030025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lönn P, van der Heide LP, Dahl M, Hellman U, Heldin CH, Moustakas A. 2010. 
PARP-1 attenuates Smad-mediated transcription. Mol Cell
40: 521–532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21095583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu Y, Jiang F, Zheng X, Katakowski M, Buller B, To SS, Chopp M. 2011. 
TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17. Oncol Rep
25: 1329–1335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3070292</ArticleId>
            <ArticleId IdType="pubmed">21359495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo K, Lodish HF. 1997. 
Positive and negative regulation of type II TGF-β receptor signal transduction by autophosphorylation on multiple serine residues. EMBO J
16: 1970–1981.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1169800</ArticleId>
            <ArticleId IdType="pubmed">9155023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo L, Ye G, Nadeem L, Fu G, Yang BB, Honarparvar E, Dunk C, Lye S, Peng C. 2012. 
MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal. J Cell Sci
125: 3124–3132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22454525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo T, Cui S, Bian C, Yu X. 2014. 
Crosstalk between TGF-β/Smad3 and BMP/BMPR2 signaling pathways via miR-17–92 cluster in carotid artery restenosis. Mol Cell Biochem
389: 169–176.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4221161</ArticleId>
            <ArticleId IdType="pubmed">24378993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lv S, Sun B, Dai C, Shi R, Zhou X, Lv W, Zhong X, Wang R, Ma W. 2014. 
The downregulation of microRNA-146a modulates TGF-β signaling pathways activity in glioblastoma. Mol Neurobiol
52: 1257–1262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25326894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malapeira J, Esselens C, Bech-Serra JJ, Canals F, Arribas J. 2011. 
ADAM17 (TACE) regulates TGF-β signaling through the cleavage of vasorin. Oncogene
30: 1912–1922.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21170088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martello G, Zacchigna L, Inui M, Montagner M, Adorno M, Mamidi A, Morsut L, Soligo S, Tran U, Dupont S, et al.
2007. 
MicroRNA control of Nodal signalling. Nature
449: 183–188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17728715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massagué J. 1998. 
TGF-β signal transduction. Annu Rev Biochem
67: 753–791.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9759503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massagué J. 2012. 
TGF-β signalling in context. Nat Rev Mol Cell Biol
13: 616–630.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4027049</ArticleId>
            <ArticleId IdType="pubmed">22992590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massagué J, Chen YG. 2000. 
Controlling TGF-β signaling. Genes Dev
14: 627–644.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10733523</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F. 2004. 
Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature
430: 226–231.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15241418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuura I, Chiang KN, Lai CY, He DM, Wang GN, Ramkumar R, Uchida T, Ryo A, Lu KP, Liu F. 2010. 
Pin1 promotes transforming growth factor-β-induced migration and invasion. J Biol Chem
285: 1754–1764.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2804333</ArticleId>
            <ArticleId IdType="pubmed">19920136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGonigle S, Beall MJ, Feeney EL, Pearce EJ. 2001. 
Conserved role for 14–3-3ɛ downstream of type I TGF-β receptors. FEBS Lett
490: 65–69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11172812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGonigle S, Beall MJ, Pearce EJ. 2002. 
Eukaryotic initiation factor 2α subunit associates with TGF-β receptors and 14-3-3ɛ and acts as a modulator of the TGF-β response. Biochemistry
41: 579–587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11781097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Millet C, Yamashita M, Heller M, Yu LR, Veenstra TD, Zhang YE. 2009. 
A negative feedback control of transforming growth factor-β signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204. J Biol Chem
284: 19808–19816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2740406</ArticleId>
            <ArticleId IdType="pubmed">19458083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miura S, Takeshita T, Asao H, Kimura Y, Murata K, Sasaki Y, Hanai JI, Beppu H, Tsukazaki T, Wrana JL, et al.
2000. 
Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. Mol Cell Biol
20: 9346–9355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC102191</ArticleId>
            <ArticleId IdType="pubmed">11094085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mizuno Y, Tokuzawa Y, Ninomiya Y, Yagi K, Yatsuka-Kanesaki Y, Suda T, Fukuda T, Katagiri T, Kondoh Y, Amemiya T, et al.
2009. 
miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett
583: 2263–2268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19520079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morén A, Imamura T, Miyazono K, Heldin CH, Moustakas A. 2005. 
Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem
280: 22115–22123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15817471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mori M, Triboulet R, Mohseni M, Schlegelmilch K, Shrestha K, Camargo FD, Gregory RI. 2014. 
Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell
156: 893–906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3982296</ArticleId>
            <ArticleId IdType="pubmed">24581491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moustakas A, Heldin CH. 2009. 
The regulation of TGF-β signal transduction. Development
136: 3699–3714.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19855013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mu Y, Sundar R, Thakur N, Ekman M, Gudey SK, Yakymovych M, Hermansson A, Dimitriou H, Bengoechea-Alonso MT, Ericsson J, et al.
2011. 
TRAF6 ubiquitinates TGF-β type I receptor to promote its cleavage and nuclear translocation in cancer. Nat Commun
2: 330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3113296</ArticleId>
            <ArticleId IdType="pubmed">21629263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T. 2003. 
Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell
14: 2809–2817.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC165678</ArticleId>
            <ArticleId IdType="pubmed">12857866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murakami K, Mathew R, Huang J, Farahani R, Peng H, Olson SC, Etlinger JD. 2010. 
Smurf1 ubiquitin ligase causes downregulation of BMP receptors and is induced in monocrotaline and hypoxia models of pulmonary arterial hypertension. Exp Biol Med
235: 805–813.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20558834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muthusamy BP, Budi EH, Katsuno Y, Lee MK, Smith SM, Mirza AM, Akhurst RJ, Derynck R. 2015. 
ShcA protects against epithelial-mesenchymal transition through compartmentalized inhibition of TGF-β-induced Smad activation. PLoS Biol
13: e1002325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4682977</ArticleId>
            <ArticleId IdType="pubmed">26680585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nagalingam RS, Sundaresan NR, Noor M, Gupta MP, Solaro RJ, Gupta M. 2014. 
Deficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor β1 (TGF-β1)-dependent paracrine mechanism. J Biol Chem
289: 27199–27214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4175354</ArticleId>
            <ArticleId IdType="pubmed">25104350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nagano Y, Mavrakis KJ, Lee KL, Fujii T, Koinuma D, Sase H, Yuki K, Isogaya K, Saitoh M, Imamura T, et al.
2007. 
Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-β signaling. J Biol Chem
282: 20492–20501.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17510063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y, Nakao S, Motoyama N, Hirao A. 2010. 
TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature
463: 676–680.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20130650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakano A, Koinuma D, Miyazawa K, Uchida T, Saitoh M, Kawabata M, Hanai J, Akiyama H, Abe M, Miyazono K, et al.
2009. 
Pin1 down-regulates transforming growth factor-β (TGF-β) signaling by inducing degradation of Smad proteins. J Biol Chem
284: 6109–6115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19122240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakano N, Itoh S, Watanabe Y, Maeyama K, Itoh F, Kato M. 2010. 
Requirement of TCF7L2 for TGF-β-dependent transcriptional activation of the TMEPAI gene. J Biol Chem
285: 38023–38033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2992236</ArticleId>
            <ArticleId IdType="pubmed">20889500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakano N, Maeyama K, Sakata N, Itoh F, Akatsu R, Nakata M, Katsu Y, Ikeno S, Togawa Y, Vo Nguyen TT, et al.
2014. 
C18 ORF1, a novel negative regulator of transforming growth factor-β signaling. J Biol Chem
289: 12680–12692.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4007458</ArticleId>
            <ArticleId IdType="pubmed">24627487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, et al.
1997. 
Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature
389: 631–635.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9335507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neel JC, Lebrun JJ. 2013. 
Activin and TGF-β regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells. Cell Signal
25: 1556–1566.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23524334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ning G, Liu X, Dai M, Meng A, Wang Q. 2013. 
MicroRNA-92a upholds Bmp signaling by targeting noggin3 during pharyngeal cartilage formation. Dev Cell
24: 283–295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23410941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nohe A, Keating E, Underhill TM, Knaus P, Petersen NO. 2005. 
Dynamics and interaction of caveolin-1 isoforms with BMP-receptors. J Cell Sci
118: 643–650.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15657086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogunjimi AA, Briant DJ, Pece-Barbara N, Le Roy C, Di Guglielmo GM, Kavsak P, Rasmussen RK, Seet BT, Sicheri F, Wrana JL. 2005. 
Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol Cell
19: 297–308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16061177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massagué J, Niehrs C. 1999. 
Silencing of TGF-β signalling by the pseudoreceptor BAMBI. Nature
401: 480–485.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10519551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oved S, Mosesson Y, Zwang Y, Santonico E, Shtiegman K, Marmor MD, Kochupurakkal BS, Katz M, Lavi S, Cesareni G, et al.
2006. 
Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases. J Biol Chem
281: 21640–21651.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16735510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. 2005. 
Regulation of the polarity protein Par6 by TGF-β receptors controls epithelial cell plasticity. Science
307: 1603–1609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15761148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Penheiter SG, Singh RD, Repellin CE, Wilkes MC, Edens M, Howe PH, Pagano RE, Leof EB. 2010. 
Type II transforming growth factor-β receptor recycling is dependent upon the clathrin adaptor protein Dab2. Mol Biol Cell
21: 4009–4019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2982134</ArticleId>
            <ArticleId IdType="pubmed">20881059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Persson U, Izumi H, Souchelnytskyi S, Itoh S, Grimsby S, Engstrom U, Heldin CH, Funa K, ten Dijke P. 1998. 
The L45 loop in type I receptors for TGF-β family members is a critical determinant in specifying Smad isoform activation. FEBS Lett
434: 83–87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9738456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petritsch C, Beug H, Balmain A, Oft M. 2000. 
TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest. Genes Dev
14: 3093–3101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC317138</ArticleId>
            <ArticleId IdType="pubmed">11124802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pierreux CE, Nicolas FJ, Hill CS. 2000. 
Transforming growth factor β-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol Cell Biol
20: 9041–9054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC86557</ArticleId>
            <ArticleId IdType="pubmed">11074002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rabut G, Peter M. 2008. 
Function and regulation of protein neddylation. “Protein modifications: Beyond the usual suspects” review series. EMBO Rep
9: 969–976.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2572130</ArticleId>
            <ArticleId IdType="pubmed">18802447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC. 2010. 
Targeting of SMAD5 links microRNA-155 to the TGF-β pathway and lymphomagenesis. Proc Natl Acad Sci
107: 3111–3116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2840369</ArticleId>
            <ArticleId IdType="pubmed">20133617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Razani B, Zhang XL, Bitzer M, von Gersdorff G, Bottinger EP, Lisanti MP. 2001. 
Caveolin-1 regulates transforming growth factor (TGF)-β/SMAD signaling through an interaction with the TGF-β type I receptor. J Biol Chem
276: 6727–6738.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11102446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Redshaw N, Camps C, Sharma V, Motallebipour M, Guzman-Ayala M, Oikonomopoulos S, Thymiakou E, Ragoussis J, Episkopou V. 2013. 
TGF-β/Smad2/3 signaling directly regulates several miRNAs in mouse ES cells and early embryos. PLoS ONE
8: e55186.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3559380</ArticleId>
            <ArticleId IdType="pubmed">23390484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reguly T, Wrana JL. 2003. 
In or out? The dynamics of Smad nucleocytoplasmic shuttling. Trends Cell Biol
13: 216–220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12742164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Remy I, Montmarquette A, Michnick SW. 2004. 
PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat Cell Biol
6: 358–365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15048128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rogler CE, Levoci L, Ader T, Massimi A, Tchaikovskaya T, Norel R, Rogler LE. 2009. 
MicroRNA-23b cluster microRNAs regulate transforming growth factor-β/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology
50: 575–584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19582816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samavarchi-Tehrani P, Golipour A, David L, Sung HK, Beyer TA, Datti A, Woltjen K, Nagy A, Wrana JL. 2010. 
Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell
7: 64–77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20621051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sapkota G, Knockaert M, Alarcon C, Montalvo E, Brivanlou AH, Massagué J. 2006. 
Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-β pathways. J Biol Chem
281: 40412–40419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17085434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato MM, Nashimoto M, Katagiri T, Yawaka Y, Tamura M. 2009. 
Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process. Biochem Biophys Res Commun
383: 125–129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19341710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schink KO, Raiborg C, Stenmark H. 2013. 
Phosphatidylinositol 3-phosphate, a lipid that regulates membrane dynamics, protein sorting and cell signalling. BioEssays
35: 900–912.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23881848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmierer B, Tournier AL, Bates PA, Hill CS. 2008. 
Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system. Proc Natl Acad Sci
105: 6608–6613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2373357</ArticleId>
            <ArticleId IdType="pubmed">18443295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seet LF, Hong W. 2001. 
Endofin, an endosomal FYVE domain protein. J Biol Chem
276: 42445–42454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11546807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. 2007. 
TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat Med
13: 1324–1332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17952090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sekiya T, Adachi S, Kohu K, Yamada T, Higuchi O, Furukawa Y, Nakamura Y, Nakamura T, Tashiro K, Kuhara S, et al.
2004a. 
Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-β signaling, as a target of the β-catenin pathway in colorectal tumor cells. J Biol Chem
279: 6840–6846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14660579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sekiya T, Oda T, Matsuura K, Akiyama T. 2004b. 
Transcriptional regulation of the TGF-β pseudoreceptor BAMBI by TGF-β signaling. Biochem Biophys Res Commun
320: 680–684.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15240101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Senanayake U, Das S, Vesely P, Alzoughbi W, Frohlich LF, Chowdhury P, Leuschner I, Hoefler G, Guertl B. 2012. 
miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis
33: 1014–1021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22431721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seoane J, Le HV, Shen L, Anderson SA, Massagué J. 2004. 
Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell
117: 211–223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15084259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sflomos G, Kostaras E, Panopoulou E, Pappas N, Kyrkou A, Politou AS, Fotsis T, Murphy C. 2011. 
ERBIN is a new SARA-interacting protein: Competition between SARA and SMAD2 and SMAD3 for binding to ERBIN. J Cell Sci
124: 3209–3222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21878490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shapira KE, Hirschhorn T, Barzilay L, Smorodinsky NI, Henis YI, Ehrlich M. 2014. 
Dab2 inhibits the cholesterol-dependent activation of JNK by TGF-β. Mol Biol Cell
25: 1620–1628.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4019493</ArticleId>
            <ArticleId IdType="pubmed">24648493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shathasivam P, Kollara A, Ringuette MJ, Virtanen C, Wrana JL, Brown TJ. 2015. 
Human ortholog of Drosophila Melted impedes SMAD2 release from TGF-β receptor I to inhibit TGF-β signaling. Proc Natl Acad Sci
112: 3000–3009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4466715</ArticleId>
            <ArticleId IdType="pubmed">26039994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen ZJ, Braun RK, Hu J, Xie Q, Chu H, Love RB, Stodola LA, Rosenthal LA, Szakaly RJ, Sorkness RL, et al.
2012. 
Pin1 protein regulates Smad protein signaling and pulmonary fibrosis. J Biol Chem
287: 23294–23305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3390608</ArticleId>
            <ArticleId IdType="pubmed">22613712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen T, Sun C, Zhang Z, Xu N, Duan X, Feng XH, Lin X. 2014. 
Specific control of BMP signaling and mesenchymal differentiation by cytoplasmic phosphatase PPM1H. Cell Res
24: 724–741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4042171</ArticleId>
            <ArticleId IdType="pubmed">24732009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi Y, Massagué J. 2003. 
Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell
113: 685–700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12809600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi W, Sun C, He B, Xiong W, Shi X, Yao D, Cao X. 2004. 
GADD34-PP1c recruited by Smad7 dephosphorylates TGF-β type I receptor. J Cell Biol
164: 291–300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2172339</ArticleId>
            <ArticleId IdType="pubmed">14718519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi W, Chang C, Nie S, Xie S, Wan M, Cao X. 2007. 
Endofin acts as a Smad anchor for receptor activation in BMP signaling. J Cell Sci
120: 1216–1224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17356069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimada K, Suzuki N, Ono Y, Tanaka K, Maeno M, Ito K. 2008. 
Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells. Bone
42: 886–893.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18321803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siomi H, Siomi MC. 2010. 
Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell
38: 323–332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20471939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siragam V, Rutnam ZJ, Yang W, Fang L, Luo L, Yang X, Li M, Deng Z, Qian J, Peng C, et al.
2012. 
MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11. Oncotarget
3: 1370–1385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3717799</ArticleId>
            <ArticleId IdType="pubmed">23211491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song H, Wang Q, Wen J, Liu S, Gao X, Cheng J, Zhang D. 2012. 
ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a. Int J Mol Sci
13: 2063–2077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3292007</ArticleId>
            <ArticleId IdType="pubmed">22408438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Souchelnytskyi S, ten Dijke P, Miyazono K, Heldin CH. 1996. 
Phosphorylation of Ser165 in TGF-β type I receptor modulates TGF-β1-induced cellular responses. EMBO J
15: 6231–6240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC452446</ArticleId>
            <ArticleId IdType="pubmed">8947046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Souchelnytskyi S, Tamaki K, Engstrom U, Wernstedt C, ten Dijke P, Heldin CH. 1997. 
Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J Biol Chem
272: 28107–28115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9346966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spiekerkoetter E, Tian X, Cai J, Hopper RK, Sudheendra D, Li CG, El-Bizri N, Sawada H, Haghighat R, Chan R, et al.
2013. 
FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. J Clin Invest
123: 3600–3613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3726153</ArticleId>
            <ArticleId IdType="pubmed">23867624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stein GS, Lian JB, Stein JL, van Wijnen AJ, Choi JY, Pratap J, Zaidi SK. 2003. 
Temporal and spatial parameters of skeletal gene expression: Targeting RUNX factors and their coregulatory proteins to subnuclear domains. Connect Tissue Res
44: 149–153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12952189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stroschein SL, Bonni S, Wrana JL, Luo K. 2001. 
Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev
15: 2822–2836.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC312804</ArticleId>
            <ArticleId IdType="pubmed">11691834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su Y, Zhang L, Gao X, Meng F, Wen J, Zhou H, Meng A, Chen YG. 2007. 
The evolutionally conserved activity of Dapper2 in antagonizing TGF-β signaling. FASEB J
21: 682–690.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17197390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun F, Wang J, Pan Q, Yu Y, Zhang Y, Wan Y, Wang J, Li X, Hong A. 2009. 
Characterization of function and regulation of miR-24-1 and miR-31. Biochem Biophys Res Commun
380: 660–665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19285018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun L, Zhang D, Liu F, Xiang X, Ling G, Xiao L, Liu Y, Zhu X, Zhan M, Yang Y, et al.
2011. 
Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192. J Pathol
225: 364–377.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3258545</ArticleId>
            <ArticleId IdType="pubmed">21984124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki C, Murakami G, Fukuchi M, Shimanuki T, Shikauchi Y, Imamura T, Miyazono K. 2002. 
Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane. J Biol Chem
277: 39919–39925.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12151385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. 2009. 
Modulation of microRNA processing by
p53
Nature
460:  529–533.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19626115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swingler TE, Wheeler G, Carmont V, Elliott HR, Barter MJ, Abu-Elmagd M, Donell ST, Boot-Handford RP, Hajihosseini MK, Munsterberg A, et al.
2012. 
The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum
64: 1909–1919.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22143896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang LY, Yamashita M, Coussens NP, Tang Y, Wang X, Li C, Deng CX, Cheng SY, Zhang YE. 2011. 
Ablation of Smurf2 reveals an inhibition in TGF-β signalling through multiple mono-ubiquitination of Smad3. EMBO J
30: 4777–4789.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3243605</ArticleId>
            <ArticleId IdType="pubmed">22045334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ten Dijke P, Heldin CH. 2006. 
The Smad family. In Smad Signal Transduction, Vol. 5 (ed. ten Dijke P, Heldin CH), pp. 1–13. Springer, Dordrecht, The Netherlands.</Citation>
        </Reference>
        <Reference>
          <Citation>Thien CB, Langdon WY. 2001. 
Cbl: Many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol
2: 294–307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11283727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thillainadesan G, Chitilian JM, Isovic M, Ablack JN, Mymryk JS, Tini M, Torchia J. 2012. 
TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex. Mol Cell
46: 636–649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22560925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tiago DM, Marques CL, Roberto VP, Cancela ML, Laize V. 2014. 
Mir-20a regulates in vitro mineralization and BMP signaling pathway by targeting BMP-2 transcript in fish. Arch Biochem Biophys
543: 23–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24361749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsai ZY, Singh S, Yu SL, Kao LP, Chen BZ, Ho BC, Yang PC, Li SS. 2010. 
Identification of microRNAs regulated by activin A in human embryonic stem cells. J Cell Biochem
109: 93–102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19885849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. 1998. 
SARA, a FYVE domain protein that recruits Smad2 to the TGF-β receptor. Cell
95: 779–791.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9865696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tu F, Pan ZX, Yao Y, Liu HL, Liu SR, Xie Z, Li QF. 2014. 
miR-34a targets the inhibin βB gene, promoting granulosa cell apoptosis in the porcine ovary. Genet Mol Res
13: 2504–2512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24446339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ueberham U, Rohn S, Ueberham E, Wodischeck S, Hilbrich I, Holzer M, Bruckner MK, Gruschka H, Arendt T. 2014. 
Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer’s disease. Neuropathol Appl Neurobiol
40: 815–832.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24964035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, Yaffe MB, Zandstra PW, Wrana JL. 2008. 
TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol
10: 837–848.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18568018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J, Pietras K, Virtanen I, Philipson L, Leopold PL, et al.
2009. 
A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial-mesenchymal transition. Nat Cell Biol
11: 943–950.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3769970</ArticleId>
            <ArticleId IdType="pubmed">19597490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wan M, Tang Y, Tytler EM, Lu C, Jin B, Vickers SM, Yang L, Shi X, Cao X. 2004. 
Smad4 protein stability is regulated by ubiquitin ligase SCF β-TrCP1. J Biol Chem
279: 14484–14487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14988407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang T, Li BY, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, Martin J, Manganaro T, Donahoe PK. 1996. 
The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors. Cell
86: 435–444.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8756725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Q, Huang Z, Xue H, Jin C, Ju XL, Han JD, Chen YG. 2008. 
MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood
111: 588–595.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17906079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang G, Matsuura I, He D, Liu F. 2009. 
Transforming growth factor-β-inducible phosphorylation of Smad3. J Biol Chem
284: 9663–9673.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2665087</ArticleId>
            <ArticleId IdType="pubmed">19218245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K. 2010a. 
TGF-β-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene
29: 1787–1797.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2845743</ArticleId>
            <ArticleId IdType="pubmed">20023698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Liu J, Zong Y, Xu Y, Deng W, Zhu H, Liu Y, Ma C, Huang L, Zhang L, et al.
2010b. 
miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer’s disease targets TGF-β type II receptor. Brain Res
1357: 166–174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20709030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Li W, Zang X, Chen N, Liu T, Tsonis PA, Huang Y. 2013. 
MicroRNA-204-5p regulates epithelial-to-mesenchymal transition during human posterior capsule opacification by targeting SMAD4. Invest Ophthalmol Vis Sci
54: 323–332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23221074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watanabe M, Masuyama N, Fukuda M, Nishida E. 2000. 
Regulation of intracellular dynamics of Smad4 by its leucine-rich nuclear export signal. EMBO Rep
1: 176–182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1084261</ArticleId>
            <ArticleId IdType="pubmed">11265759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watanabe Y, Itoh S, Goto T, Ohnishi E, Inamitsu M, Itoh F, Satoh K, Wiercinska E, Yang W, Shi L, et al.
2010. 
TMEPAI, a transmembrane TGF-β-inducible protein, sequesters Smad proteins from active participation in TGF-β signaling. Mol Cell
37: 123–134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20129061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watson IR, Irwin MS, Ohh M. 2011. 
NEDD8 pathways in cancer, Sine Quibus Non. Cancer Cell
19: 168–176.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21316600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weiss A, Attisano L. 2013. 
The TGF-β superfamily signaling pathway. Wiley Interdiscip Rev Dev Biol
2: 47–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23799630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wicks SJ, Haros K, Maillard M, Song L, Cohen RE, Dijke PT, Chantry A. 2005. 
The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-β signalling. Oncogene
24: 8080–8084.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16027725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wieser R, Wrana JL, Massagué J. 1995. 
GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J
14: 2199–2208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC398326</ArticleId>
            <ArticleId IdType="pubmed">7774578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willis SA, Zimmerman CM, Li LI, Mathews LS. 1996. 
Formation and activation by phosphorylation of activin receptor complexes. Mol Endocrinol
10: 367–379.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8721982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wrana JL, Attisano L, Cárcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massagué J. 1992. 
TGF-β signals through a heteromeric protein kinase receptor complex. Cell
71: 1003–1014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1333888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. 1994. 
Mechanism of activation of the TGF-β receptor. Nature
370: 341–347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8047140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wrighton KH, Lin X, Feng XH. 2008. 
Critical regulation of TGF-β signaling by Hsp90. Proc Natl Acad Sci
105: 9244–9249.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2453700</ArticleId>
            <ArticleId IdType="pubmed">18591668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu G, Chen YG, Ozdamar B, Gyuricza CA, Chong PA, Wrana JL, Massagué J, Shi Y. 2000. 
Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Science
287: 92–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10615055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu T, Zhou H, Hong Y, Li J, Jiang X, Huang H. 2012. 
miR-30 family members negatively regulate osteoblast differentiation. J Biol Chem
287: 7503–7511.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3293535</ArticleId>
            <ArticleId IdType="pubmed">22253433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xi Q, Wang Z, Zaromytidou AI, Zhang XH, Chow-Tsang LF, Liu JX, Kim H, Barlas A, Manova-Todorova K, Kaartinen V, et al.
2011. 
A poised chromatin platform for TGF-β access to master regulators. Cell
147: 1511–1524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3582033</ArticleId>
            <ArticleId IdType="pubmed">22196728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao Z, Liu X, Lodish HF. 2000. 
Importin β mediates nuclear translocation of Smad 3. J Biol Chem
275: 23425–23428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10846168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao Z, Watson N, Rodriguez C, Lodish HF. 2001. 
Nucleocytoplasmic shuttling of Smad1 conferred by its nuclear localization and nuclear export signals. J Biol Chem
276: 39404–39410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11509558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao Z, Brownawell AM, Macara IG, Lodish HF. 2003a. 
A novel nuclear export signal in Smad1 is essential for its signaling activity. J Biol Chem
278: 34245–34252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12821673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao Z, Latek R, Lodish HF. 2003b. 
An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity. Oncogene
22: 1057–1069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12592392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, Wang F, Wu Y, Tong WD, et al.
2009. 
Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis
200: 916–925.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19650740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu L, Massagué J. 2004. 
Nucleocytoplasmic shuttling of signal transducers. Nat Rev Mol Cell Biol
5: 209–219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14991001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu L, Chen YG, Massagué J. 2000. 
The nuclear import function of Smad2 is masked by SARA and unmasked by TGF-β-dependent phosphorylation. Nat Cell Biol
2: 559–562.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10934479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu L, Kang Y, Col S, Massagué J. 2002. 
Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGF-β signaling complexes in the cytoplasm and nucleus. Mol Cell
10: 271–282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12191473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu L, Alarcon C, Col S, Massagué J. 2003. 
Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. J Biol Chem
278: 42569–42577.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12917407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu L, Yao X, Chen X, Lu P, Zhang B, Ip YT. 2007. 
Msk is required for nuclear import of TGF-β/BMP-activated Smads. J Cell Biol
178: 981–994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2064622</ArticleId>
            <ArticleId IdType="pubmed">17785517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu P, Liu J, Derynck R. 2012. 
Post-translational regulation of TGF-β receptor and Smad signaling. FEBS Lett
586: 1871–1884.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4240271</ArticleId>
            <ArticleId IdType="pubmed">22617150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamaguchi T, Kurisaki A, Yamakawa N, Minakuchi K, Sugino H. 2006. 
FKBP12 functions as an adaptor of the Smad7–Smurf1 complex on activin type I receptor. J Mol Endocrinol
36: 569–579.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16720724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamakawa N, Tsuchida K, Sugino H. 2002. 
The rasGAP-binding protein, Dok-1, mediates activin signaling via serine/threonine kinase receptors. EMBO J
21: 1684–1694.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC125939</ArticleId>
            <ArticleId IdType="pubmed">11927552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamashita H, ten Dijke P, Franzen P, Miyazono K, Heldin CH. 1994. 
Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem
269: 20172–20178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8051105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamashita M, Fatyol K, Jin CY, Wang XC, Liu ZG, Zhang YE. 2008. 
TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β. Mol Cell
31: 918–924.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2621323</ArticleId>
            <ArticleId IdType="pubmed">18922473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan X, Chen YG. 2011. 
Smad7: Not only a regulator, but also a cross-talk mediator of TGF-β signalling. Biochem J
434: 1–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21269274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning Y, Chen YG. 2009. 
Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-β signaling. J Biol Chem
284: 30097–30104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2781564</ArticleId>
            <ArticleId IdType="pubmed">19758997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan X, Zhang J, Pan L, Wang P, Xue H, Zhang L, Gao X, Zhao X, Ning Y, Chen YG. 2011. 
TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity. Mol Cell Biol
31: 3700–3709.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3165719</ArticleId>
            <ArticleId IdType="pubmed">21791611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan G, Zhang L, Fang T, Zhang Q, Wu S, Jiang Y, Sun H, Hu Y. 2012. 
MicroRNA-145 suppresses mouse granulosa cell proliferation by targeting activin receptor IB. FEBS Lett
586: 3263–3270.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22796494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang KM, Kim W, Bae E, Gim J, Weist BM, Jung Y, Hyun JS, Hernandez JB, Leem SH, Park T, et al.
2012. 
DRAK2 participates in a negative feedback loop to control TGF-β/Smads signaling by binding to type I TGF-β receptor. Cell Rep
2: 1286–1299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23122956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang H, Fang F, Chang R, Yang L. 2013. 
MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology
58: 205–217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23401231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao D, Dore JJ Jr, Leof EB. 2000. 
FKBP12 is a negative regulator of transforming growth factor-β receptor internalization. J Biol Chem
275: 13149–13154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10777621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao G, Yin M, Lian J, Tian H, Liu L, Li X, Sun F. 2010. 
MicroRNA-224 is involved in transforming growth factor-β-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol Endocrinol
24: 540–551.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5419098</ArticleId>
            <ArticleId IdType="pubmed">20118412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin Q, Wang X, Fewell C, Cameron J, Zhu H, Baddoo M, Lin Z, Flemington EK. 2010. 
MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein–Barr virus reactivation. J Virol
84: 6318–6327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2903268</ArticleId>
            <ArticleId IdType="pubmed">20427544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu L, Hebert MC, Zhang YE. 2002. 
TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J
21: 3749–3759.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC126112</ArticleId>
            <ArticleId IdType="pubmed">12110587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu J, Pan L, Qin X, Chen H, Xu Y, Chen Y, Tang H. 2010. 
MTMR4 attenuates transforming growth factor β (TGF-β) signaling by dephosphorylating R-Smads in endosomes. J Biol Chem
285: 8454–8462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2832994</ArticleId>
            <ArticleId IdType="pubmed">20061380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu J, He X, Chen YG, Hao Y, Yang S, Wang L, Pan L, Tang H. 2013. 
Myotubularin-related protein 4 (MTMR4) attenuates BMP/Dpp signaling by dephosphorylation of Smad proteins. J Biol Chem
288: 79–88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3537074</ArticleId>
            <ArticleId IdType="pubmed">23150675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yukita A, Hosoya A, Ito Y, Katagiri T, Asashima M, Nakamura H. 2012. 
Ubc9 negatively regulates BMP-mediated osteoblastic differentiation in cultured cells. Bone
50: 1092–1099.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22366399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zaidi SK, Sullivan AJ, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 2002. 
Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci
99: 8048–8053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC123018</ArticleId>
            <ArticleId IdType="pubmed">12060751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R. 2001. 
Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci
98: 974–979.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC14694</ArticleId>
            <ArticleId IdType="pubmed">11158580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Zhou H, Su Y, Sun Z, Zhang H, Zhang Y, Ning Y, Chen YG, Meng A. 2004. 
Zebrafish Dpr2 inhibits mesoderm induction by promoting degradation of nodal receptors. Science
306: 114–117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15459392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang W, Jiang Y, Wang Q, Ma X, Xiao Z, Zuo W, Fang X, Chen YG. 2009. 
Single-molecule imaging reveals transforming growth factor-β-induced type II receptor dimerization. Proc Natl Acad Sci
106: 15679–15683.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2747179</ArticleId>
            <ArticleId IdType="pubmed">19720988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang W, Yuan J, Yang Y, Xu L, Wang Q, Zuo W, Fang X, Chen YG. 2010. 
Monomeric type I and type III transforming growth factor-β receptors and their dimerization revealed by single-molecule imaging. Cell Res
20: 1216–1223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20625381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Zhou F, Drabsch Y, Gao R, Snaar-Jagalska BE, Mickanin C, Huang H, Sheppard KA, Porter JA, Lu CX, et al.
2012. 
USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Nat Cell Biol
14: 717–726.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22706160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Zhou F, Garcia de Vinuesa A, de Kruijf EM, Mesker WE, Hui L, Drabsch Y, Li Y, Bauer A, Rousseau A, et al.
2013a. 
TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. Mol Cell
51: 559–572.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23973329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q, Sun H, Jiang Y, Ding L, Wu S, Fang T, Yan G, Hu Y. 2013b. 
MicroRNA-181a suppresses mouse granulosa cell proliferation by targeting activin receptor IIA. PLoS ONE
8: e59667.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3604175</ArticleId>
            <ArticleId IdType="pubmed">23527246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang J, Ma W, Tian S, Fan Z, Ma X, Yang X, Zhao Q, Tan K, Chen H, Chen D, et al.
2014. 
RanBPM interacts with TβRI, TRAF6 and curbs TGF induced nuclear accumulation of TβRI. Cell Signal
26: 162–172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24103590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Wang Q, Du J, Luo S, Xia J, Chen YG. 2012. 
PICK1 promotes caveolin-dependent degradation of TGF-β type I receptor. Cell Res
22: 1467–1478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3463259</ArticleId>
            <ArticleId IdType="pubmed">22710801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao Y, Xiao M, Sun B, Zhang Z, Shen T, Duan X, Yu PB, Feng XH, Lin X. 2014. 
C-terminal domain (CTD) small phosphatase-like 2 modulates the canonical bone morphogenetic protein (BMP) signaling and mesenchymal differentiation via Smad dephosphorylation. J Biol Chem
289: 26441–26450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4176200</ArticleId>
            <ArticleId IdType="pubmed">25100727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhong X, Chung AC, Chen HY, Meng XM, Lan HY. 2011. 
Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol
22: 1668–1681.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3171938</ArticleId>
            <ArticleId IdType="pubmed">21852586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH. 1999. 
A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature
400: 687–693.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10458166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu L, Wang L, Luo X, Zhang Y, Ding Q, Jiang X, Wang X, Pan Y, Chen Y. 2012. 
Tollip, an intracellular trafficking protein, is a novel modulator of the transforming growth factor-β signaling pathway. J Biol Chem
287: 39653–39663.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3501082</ArticleId>
            <ArticleId IdType="pubmed">23027871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zumbrennen-Bullough KB, Wu Q, Core AB, Canali S, Chen W, Theurl I, Meynard D, Babitt JL. 2014. 
MicroRNA-130a is up-regulated in mouse liver by iron deficiency and targets the bone morphogenetic protein (BMP) receptor ALK2 to attenuate BMP signaling and hepcidin transcription. J Biol Chem
289: 23796–23808.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4156078</ArticleId>
            <ArticleId IdType="pubmed">25002578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zuo W, Chen YG. 2009. 
Specific activation of mitogen-activated protein kinase by transforming growth factor-β receptors in lipid rafts is required for epithelial cell plasticity. Mol Biol Cell
20: 1020–1029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2633387</ArticleId>
            <ArticleId IdType="pubmed">19056678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zuo W, Huang F, Chiang YJ, Li M, Du J, Ding Y, Zhang T, Lee HW, Jeong LS, Chen Y, et al.
2013. 
c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor. Mol Cell
49: 499–510.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23290524</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
